Exploring Determinants of COVID-19 Vaccine Acceptance, Uptake, and Hesitancy in the Pediatric Population: A Study of Parents and Caregivers in Saudi Arabia during the Initial Vaccination Phase

Abstract

Objectives: This study aims to assess COVID-19 vaccine acceptance, uptake, and hesitancy among parents and caregivers of children in Saudi Arabia during the initial rollout of pediatric COVID-19 vaccination. Methods: An electronic survey was used to collect data from participants who visited a COVID-19 vaccine center. The survey included demographic data, COVID-19 vaccine status among participants and their children, and reasons for vaccine acceptance or rejection. The Vaccine Hesitancy Scale (VHS) tool was also employed to assess vaccine hesitancy and attitudes toward the COVID-19 vaccine and routine childhood vaccination. Multivariate binary regression analysis was used to identify predictors of actual COVID-19 vaccine uptake among children. Results: Of the 873 respondents included in the analysis, 61.5% were parents and 38.5% were other caregivers. Of the participants, 96.9% had received the COVID-19 vaccine. Six hundred and ninety-four participants accepted the vaccine for their children, with the main reasons being an endorsement by the Saudi Ministry of Health (60%) and the importance of going back to school (55%). One hundred and seventy-nine participants would not vaccinate their children, with the most common reasons being fear of adverse effects (49%) and inadequate data about vaccine safety (48%). Factors such as age, COVID-19 vaccination status, self-rated family commitment level, attitudes toward routine children’s vaccines, and participants’ generalized anxiety disorder (GAD7) score did not significantly correlate with children’s COVID-19 vaccination status. Parents were less likely to vaccinate their children compared to other caregivers, and participants with a higher socioeconomic status were more likely to vaccinate their children. Conclusion: Vaccine acceptance and uptake were high during the initial pediatric COVID-19 vaccination rollout in Saudi Arabia. Still, the ongoing endorsement of the Ministry of Health and healthcare authorities should continue to advocate for better vaccine uptake in children.

Assessing the Efficacy of the 3R (Reframe, Reprioritize, and Reform) Communication Model to Increase HPV Vaccinations Acceptance in Ghana: Community-Based Intervention

“…Indeed, attitudes such as perceived benefit and risk have been shown to be related to HPV vaccination acceptance [ 60 , 61 ]. Our findings are consistent with similar patterns observed in COVID-19 vaccination, with hesitancy linked to concerns about effectiveness, safety, and necessity [ 62 ]. Communication programs focusing on individual benefits can increase vaccine intention and uptake.…”

“…Communication programs focusing on individual benefits can increase vaccine intention and uptake. Healthcare authorities can target hesitant parents through campaigns and endorsements, while using validated vaccine hesitancy scales to measure hesitancy consistently and develop targeted interventions [ 62 ].…”

Evaluating COVID-19 vaccine acceptance among parents in Saudi Arabia: a systematic review examining attitudes, hesitancy, and intentions

“…This review identified parental age as one of the main factors described in 9 (out of 23) studies, influencing parents' intention to vaccinate their children against COVID-19. However, this is hard to interpret as out of the 23 included studies, only three studies (16,19,21) included age as a continuous variable. The remaining studies categorized age into different age categories without providing a valid rationale for such a categorization.…”

“…Altulaihi and colleagues described that the presence of extended family support was linked to parents' willingness to vaccinate their children against COVID-19 (8). Other factors included the mutual involvement of both parents in decisions regarding the child's care (16) and the type of COVID-19 vaccine to be given to the child (21).…”

Dose Intervals and Time since Final Dose on Changes in Metabolic Indices after COVID-19 Vaccination

“…Advised by the Saudi Ministry of Health (MOH) and international health organizations, the government launched its vaccination campaign in December 2020, adopting a phased approach that focused initially on high-risk groups and healthcare workers. In August 2021, the government opened vaccination eligibility to all adults aged 18 years and above [ 15 ]. The vaccination program involved procuring and distributing various COVID-19 vaccines as they received regulatory approval, including those developed by Pfizer-BioNTech, AstraZeneca, Moderna, and others [ 16 ].…”